Evaluation of Two Epoetin Alfa Dosing Strategies in Subjects With Chronic Kidney Disease Receiving Hemodialysis

Clinical trial NCT02253654 · COMPLETED

Trial details

NCT number: NCT02253654
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Renal Insufficiency, Chronic Anemia Renal Dialysis Erythrocyte Transfusion

Start date: 2015-04-01
Primary completion: 2016-04-27
Enrollment: 216

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.